Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Leukemia
November 4, 2019 — Oncology News & Updates
Genomic Testing
,
Financial Toxicity
,
Leukemia
,
Web Exclusives
Read More ›
Mechanism of Pathway: Considerations of Cytogenetic and Molecular Mutation Status for Patients with Acute Myeloid Leukemia: A Deeper Look at the Role of Diagnostic and Ongoing Testing Across the Care Continuum
Leukemia
Read More ›
Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and
FLT3-ITD
Mutation
Leukemia
,
Web Exclusives
Read More ›
Venetoclax plus Rituximab New Chemotherapy-Free Option for Chronic Lymphocytic Leukemia
By
Phoebe Starr
Web Exclusives
,
Leukemia
Read More ›
New BTK Inhibitor Leads to Durable Responses in Relapsed or Refractory Chronic Lymphocytic Leukemia
By
Charles Bankhead
Web Exclusives
,
Leukemia
Read More ›
Ibrutinib plus Venetoclax Combo Elicits Impressive Responses in Relapsed Chronic Lymphocytic Leukemia
By
Wayne Kuznar
Web Exclusives
,
Leukemia
Read More ›
Recent FDA Approvals for ALL a “Watershed” Moment
By
Chase Doyle
Web Exclusives
,
Leukemia
Read More ›
Leukemia Stem Cell Phenotypes Associated with Outcomes
Leukemia
Read More ›
Molecular Subtype-Specific Therapy in DLBCL
Leukemia
Read More ›
GADOLIN Trial: Obinutuzumab Moves into Indolent Lymphoma
Leukemia
Read More ›
Page 1 of 4
1
2
3
4